Raymond James Financial Services Advisors’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.2M | Sell |
18,025
-589
| -3% | -$104K | ﹤0.01% | 1471 |
|
|
2024
Q2 | $3.13M | Sell |
18,614
-566
| -3% | -$95.3K | ﹤0.01% | 1419 |
|
|
2024
Q1 | $3.19M | Buy |
19,180
+51
| +0.3% | +$8.48K | ﹤0.01% | 1389 |
|
|
2023
Q4 | $3.16M | Buy |
19,129
+4,909
| +35% | +$811K | 0.01% | 1321 |
|
|
2023
Q3 | $2.21M | Buy |
14,220
+521
| +4% | +$81.1K | ﹤0.01% | 1449 |
|
|
2023
Q2 | $2.14M | Buy |
13,699
+2,044
| +18% | +$319K | ﹤0.01% | 1473 |
|
|
2023
Q1 | $1.89M | Buy |
11,655
+59
| +0.5% | +$9.56K | ﹤0.01% | 1522 |
|
|
2022
Q4 | $1.85M | Sell |
11,596
-58
| -0.5% | -$9.27K | ﹤0.01% | 1479 |
|
|
2022
Q3 | $1.64M | Buy |
11,654
+1,190
| +11% | +$168K | ﹤0.01% | 1531 |
|
|
2022
Q2 | $1.53M | Sell |
10,464
-121
| -1% | -$17.6K | ﹤0.01% | 1596 |
|
|
2022
Q1 | $1.72M | Buy |
10,585
+4,295
| +68% | +$696K | ﹤0.01% | 1590 |
|
|
2021
Q4 | $1.19M | Buy |
6,290
+171
| +3% | +$32.4K | ﹤0.01% | 1861 |
|
|
2021
Q3 | $1.24M | Buy |
6,119
+74
| +1% | +$15K | ﹤0.01% | 1812 |
|
|
2021
Q2 | $1.22M | Sell |
6,045
-99
| -2% | -$20K | ﹤0.01% | 1812 |
|
|
2021
Q1 | $1.08M | Buy |
6,144
+134
| +2% | +$23.5K | ﹤0.01% | 1797 |
|
|
2020
Q4 | $1.02M | Sell |
6,010
-415
| -6% | -$70.4K | ﹤0.01% | 1687 |
|
|
2020
Q3 | $1.04M | Buy |
6,425
+431
| +7% | +$69.9K | ﹤0.01% | 1530 |
|
|
2020
Q2 | $977K | Buy |
5,994
+1,745
| +41% | +$284K | ﹤0.01% | 1498 |
|
|
2020
Q1 | $544K | Buy |
4,249
+331
| +8% | +$42.4K | ﹤0.01% | 1489 |
|
|
2019
Q4 | $546K | Buy |
+3,918
| New | +$546K | ﹤0.01% | 1923 |
|
|
2018
Q4 | – | Sell |
-8,864
| Closed | -$1.21M | – | 2557 |
|
|
2018
Q3 | $1.21M | Buy |
8,864
+1,205
| +16% | +$164K | 0.01% | 1352 |
|
|
2018
Q2 | $919K | Buy |
7,659
+1,217
| +19% | +$146K | ﹤0.01% | 1470 |
|
|
2018
Q1 | $776K | Sell |
6,442
-4,493
| -41% | -$541K | ﹤0.01% | 1469 |
|
|
2017
Q4 | $1.36M | Buy |
10,935
+6,643
| +155% | +$829K | 0.01% | 1108 |
|
|
2017
Q3 | $576K | Buy |
4,292
+383
| +10% | +$51.4K | ﹤0.01% | 1631 |
|
|
2017
Q2 | $491K | Buy |
3,909
+643
| +20% | +$80.8K | ﹤0.01% | 1684 |
|
|
2017
Q1 | $389K | Buy |
3,266
+199
| +6% | +$23.7K | ﹤0.01% | 1724 |
|
|
2016
Q4 | $330K | Sell |
3,067
-451
| -13% | -$48.5K | ﹤0.01% | 1758 |
|
|
2016
Q3 | $405K | Buy |
3,518
+635
| +22% | +$73.1K | ﹤0.01% | 1609 |
|
|
2016
Q2 | $295K | Buy |
2,883
+264
| +10% | +$27K | ﹤0.01% | 1728 |
|
|
2016
Q1 | $272K | Buy |
+2,619
| New | +$272K | ﹤0.01% | 1601 |
|